About Combinent Biomedical Systems
Combinent Biomedical Systems is a company based in Lexington (United States) founded in 2000 by Eric Gordon. It operates as a B2B. Combinent Biomedical Systems has raised $5.12 million across 6 funding rounds from investors including Cytyc, VIMAC Ventures and Commons Capital. Combinent Biomedical Systems operates in a competitive market with competitors including Evestra, Inura Medical, BeyonDevices, VaRi Bioscience and Cytokine PharmaSciences, among others.
- Headquarter Lexington, United States
- Founders Eric Gordon
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.12 M (USD)
in 6 rounds
-
Latest Funding Round
$600 K (USD), Series A
Oct 01, 2012
-
Investors
Cytyc
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Combinent Biomedical Systems
Combinent Biomedical Systems has successfully raised a total of $5.12M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $600 thousand completed in October 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $600,000
-
First Round
First Round
(08 May 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2012 | Amount | Series A - Combinent Biomedical Systems | Valuation |
investors |
|
| Jan, 2012 | Amount | Debt – Conventional - Combinent Biomedical Systems | Valuation |
investors |
|
| Dec, 2010 | Amount | Series A - Combinent Biomedical Systems | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Combinent Biomedical Systems
Combinent Biomedical Systems has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Cytyc, VIMAC Ventures and Commons Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Commons Capital is engaged in venture capital investments for sustainable companies.
|
Founded Year | Domain | Location | |
|
Diagnostic medical devices for cancer and women's health are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Combinent Biomedical Systems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Combinent Biomedical Systems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Combinent Biomedical Systems Comparisons
Competitors of Combinent Biomedical Systems
Combinent Biomedical Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evestra, Inura Medical, BeyonDevices, VaRi Bioscience and Cytokine PharmaSciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Products for women's reproductive health needs are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Develops innovative drug delivery devices for treating overactive bladder.
|
|
| domain | founded_year | HQ Location |
Vaginal applicators are manufactured for proper medicine delivery.
|
|
| domain | founded_year | HQ Location |
Drug delivery vaginal rings for women's health are developed.
|
|
| domain | founded_year | HQ Location |
Controlled-release drug delivery products for women's health are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Combinent Biomedical Systems
Frequently Asked Questions about Combinent Biomedical Systems
When was Combinent Biomedical Systems founded?
Combinent Biomedical Systems was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Where is Combinent Biomedical Systems located?
Combinent Biomedical Systems is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Combinent Biomedical Systems a funded company?
Combinent Biomedical Systems is a funded company, having raised a total of $5.12M across 6 funding rounds to date. The company's 1st funding round was a Series A of $1.02M, raised on May 08, 2007.
What does Combinent Biomedical Systems do?
Combinent Biomedical Systems develops transvaginal drug delivery systems for womens reproductive endocrinology disorders, focusing on providing healthcare solutions, advancing biotech innovations, developing medical devices, and drug delivery. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Who are the top competitors of Combinent Biomedical Systems?
Combinent Biomedical Systems's top competitors include Evestra, BeyonDevices and AnelleO.
Who are Combinent Biomedical Systems's investors?
Combinent Biomedical Systems has 3 investors. Key investors include Cytyc, VIMAC Ventures, and Commons Capital.